The International Business and Investment Forum on “Mobilizing investment, technology and partnership opportunities for Africa’s pharmaceutical industry” gathered some 70 participants at the UN Campus in Bonn, Germany from 1 – 2 March 2018.
The forum offered a platform for African pharmaceutical manufacturers, who have been part of a United Nations Industrial Development Organization (UNIDO) – supported mentoring process, to explore partnership opportunities with German pharmaceutical companies and potential investors.
For the German participants, the forum further offered an introduction to African pharma markets and the business environment, supplemented by presentations and discussions around three key topics: market access, access to affordable finance, and access to technology. German companies learnt about the market opportunities that a growing middle class with increased purchasing power, and with disease patterns, beyond the pandemic diseases, that resemble those in more advanced geographies, ought to offer for investments in the medium term.
Dr. Raju Mohindra and Mrs. Reema Mohindra
At UN Campus, Bonn, Germany
Almost 200 B2B conversations between pharmaceutical manufacturers from Africa and Germany/Europe served to explore options for future business partnerships.
Financing institutions such as DEG Germany, Catalyst Principal Partners, Acumen Fund East Africa, and other major players, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria were in attendance.
The Federation of African Pharmaceutical Manufacturers Associations (FAPMA), the Southern African Generics Medicines Association (SAGMA), the Federation of East African Pharmaceutical Manufacturer Associations (FEAPM) and the West African Pharmaceutical Manufacturers Association (WAPMA) also attended. Africa’s pharmaceutical industry was represented by companies from Ghana, Kenya (Dawa Limited), Namibia, Uganda, South Africa, Zambia and Zimbabwe.